Prophylaxis of migraine

Active Ingredient: Flunarizine

Indication for Flunarizine

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
Therapeutic intent: Preventive action

The limited information available for periods longer than 12 months has shown flunarizine to continue to be effective. Patients should be regularly reviewed to assess their response to treatment, and if a sustained attack-free period is established, interrupted flunarizine treatment should be considered.

For this indication, competent medicine agencies globally authorize below treatments:

10 mg daily and thereafer 10 mg daily interrupted by two successive drug-free days every week

For:

Dosage regimens

Oral, 10 milligrams flunarizine, once daily at the end of the day, over the duration of 2 months. Afterwards, oral, 10 milligrams flunarizine, divided weekly at the end of the day, 5 doses in total, over the duration of 4 months.

Detailed description

Treatment is started at 10 mg daily (at night) for adult patients aged 18 to 64 years. If, during this treatment, depressive, extrapyramidal or other unacceptable adverse experiences occur, administration should be discontinued. If, after 2 months of this initial treatment, no significant improvement is observed, the patient should be considered a non-responder and administration should be discontinued.

Maintenance Treatment

If the patient is responding satisfactorily and a maintenance treatment is needed, the same daily dose should be used, but this time interrupted by two successive drug-free days every week, eg Saturday and Sunday.

Even if the prophylactic maintenance treatment is successful and well tolerated, it should be interrupted after 6 months and it should be re-initiated only if the patient relapses.

Dosage considerations

At night.

5 mg daily and thereafer 5 mg daily interrupted by two successive drug-free days every week

For:

Dosage regimens

Oral, 5 milligrams flunarizine, once daily, over the duration of 2 months. Afterwards, oral, 5 milligrams flunarizine, divided weekly, 5 doses in total, over the duration of 4 months.

Detailed description

Starting Dose

Treatment is started at 5 mg daily (at night) for elderly patients aged 65 years and older. If, during this treatment, depressive, extrapyramidal or other unacceptable adverse experiences occur, administration should be discontinued. If, after 2 months of this initial treatment, no significant improvement is observed, the patient should be considered a non-responder and administration should be discontinued.

Maintenance Treatment

If the patient is responding satisfactorily and a maintenance treatment is needed, the same daily dose should be used, but this time interrupted by two successive drug-free days every week, eg Saturday and Sunday.

Even if the prophylactic maintenance treatment is successful and well tolerated, it should be interrupted after 6 months and it should be re-initiated only if the patient relapses.

Dosage considerations

At night.

5 mg daily and 5-10 mg daily in patients weighting more than 40 kg

For:

Dosage regimens

Regimen A: Oral, 5 milligrams flunarizine, once daily, over the duration of 6 months.

Regimen B: In case that patient weight is ≥ 40 kg, oral, between 5 milligrams flunarizine and 10 milligrams flunarizine, once daily, over the duration of 6 months. The maximum allowed total dose is 10 milligrams flunarizine daily.

Detailed description

The maximum recommended treatment duration is 6 months.

Dosage considerations

At night.

Active ingredient

Flunarizine

Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.

Read more about Flunarizine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.